The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review
Medical Sciences · 02.02.2026 · 14 (1) · 68
DOI: 10.3390/medsci14010068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 02.02.2026. Verfasst von Pietro Bellini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Iodine Radioisotopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Differentiated thyroid carcinoma (DTC) is the most common malignant endocrine tumor, with a generally favorable prognosis. Imaging, including iodine radioactive isotope scintigraphy (IRIS), is crucial for diagnosis and follow-up. While 131I has long been used for both therapeutic and diagnostic purposes, 123I is reserved for diagnostic imaging due to its shorter half-life and γ emissions. This review highlights the utility of 123I scintigraphy, especially in pre-treatment assessment and dosimetry for DTC. It is particularly valuable before radioiodine (RAI) ablation, providing accurate imaging in patients with iodine-refractory (IR) or biochemically incomplete response (BIR) DTC. When compared to post-therapeutic 131I scans, 123I scintigraphy appears to have a lower sensitivity for detecting metastatic lesions, particularly in lymph nodes and lungs. However, its diagnostic performance compared to low-dose diagnostic 131I is more variable, with some studies suggesting superiority due to the absence of stunning. Further research is needed to standardize its use and optimize its role in guiding DTC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
- Nuclear Medicine, ASST Spedali Civili di Brescia and University of Brescia, 25123 Brescia, Italy.
- Clinical Engineering, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
- Department of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, ASST Spedali Civili, 25123 Brescia, Italy.
- Otolaryngology Unit, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
- Surgical Clinic, Università Degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
ORCID-Profile: Pietro Bellini, Francesco Dondi, Michela Cossandi, Carlo Cappelli, Elisa Gatta, Luigi Spiazzi
Zitieren
APA
Bellini, P., Dondi, F., Cossandi, M., Viganò, G., Cappelli, C., Gatta, E., Lombardi, D., Morandi, R., Casella, C., Spiazzi, L., Rodella, C., Saiani, F., Ingraito, C., Zilioli, V., & Bertagna, F. (2026). The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review. Medical Sciences, 14(1), 68. https://doi.org/10.3390/medsci14010068
Vancouver
Bellini P, Dondi F, Cossandi M, Viganò G, Cappelli C, Gatta E, et al. The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review. Medical Sciences. 2026;14(1):68. doi:10.3390/medsci14010068
BibTeX
@article{Bellini2026,
author = {Bellini, Pietro and Dondi, Francesco and Cossandi, Michela and Viganò, Gianluca and Cappelli, Carlo and Gatta, Elisa and Lombardi, Davide and Morandi, Riccardo and Casella, Claudio and Spiazzi, Luigi and Rodella, Carlo and Saiani, Federica and Ingraito, Chiara and Zilioli, Valentina and Bertagna, Francesco},
title = {The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {68},
doi = {10.3390/medsci14010068}
}
EUVIMED